Clinical responses and synovial vascularity in obese rheumatoid arthritis patients treated with adalimumab and methotrexate
doi:10.1016/s0168-8278(98)80311-5
Clin Cases Mineral Bone Metabolism 5:101 Weiner DE (2009) Public health consequences of chronic kidney disease
Qiao Y, Wang J, Mao Y, Liu M, Chen RN, Su YQ
Intermediates of betaine/choline metabolismincluding phosphoethanolamine, phosphocholine, and cholinealso varied with clinical improvement across domains, although not all comparisons reached statistical significance
Now their stomachs are paralyzed July 25, 2023 Facial lipoatrophy with semaglutide-related weight loss February 10, 2023 --------------------------------------- Glucagon-like peptide 1 (GLP-1) agonists are medications approved for treatment of diabetes that recently have also been used off label for weight loss.1 Studies have found increased risks of gastrointestinal adverse events (biliary disease,2 pancreatitis,3 bowel obstruction,4 and gastroparesis5) in patients with diabetes.2-5 Because such patients have higher baseline risk for gastrointestinal adverse events, risk in patients taking these drugs for other indications may differ